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Objective: This article reports the early clinical outcomes and experiences of Zenith pivot branch device (p-branch)
standard fenestrated endovascular graft (Cook, Bloomington, Ind) for treating juxtarenal abdominal aortic aneurysm
(AAA) originating below the superior mesenteric artery (SMA).
Methods: A physician-sponsored investigational device exemption study was used to assess enrolled elective and emergency
patients from August 2011 to September 2012 for treatment with an off-the-shelf Zenith p-branch device. Patients were
included provided an anatomic seal could be established 4 mm below the SMA and the renal geometry ﬁt the protocol
based on reconstructed computed tomography data. The celiac artery was addressed with a scallop and the SMA with an
8-mm fenestration. The renal fenestrations were constructed as a modiﬁed design to allow a range of renal locations (7.5
mm radially from the center of the fenestration) to be acceptably treated with a single conﬁguration. Two anatomic
conﬁgurations were created for renal arteries (origins at the same level, or disparate renal arteries with left lower than
right). Outcomes are reported in coherence with endovascular reporting standards documents.
Results: The study enrolled 16 patients (94% men; median age, 75 years [range, 59-87 years]) with a mean aneurysm size
of 61 mm (range, 52-82 mm). Two were treated for aneurysm rupture. Technical success was achieved in all patients. The
median ﬂuoroscopy time was 62 minutes (range, 38-105 minutes), and the amount of contrast media was 69 mL (range,
31-121 mL). There were no aortic-related deaths, aneurysm ruptures, open surgical conversion, or type I/III endoleaks.
One right renal artery occluded during follow-up in the setting of a conically shaped visceral aortic segment and was
successfully treated with endovascular recanalization.
Conclusions: The use of the p-branch device for aneurysms originating infra-SMA is associated with a high rate of technical
success and minimal problems during the short follow-up duration. The off-the-shelf design allows for the treatment of
ruptures and other urgent situations. Additional patients and more follow-up will be required to further deﬁne the risks
and beneﬁts of such a treatment strategy. (J Vasc Surg 2013;58:291-301.)Endovascular aortic repair (EVAR) has become the
primary means of treating infrarenal abdominal aortic
aneurysms (AAAs).1-3 Complex proximal neck anatomy
and aneurysmal extension of disease into the visceral
segments represent the most common contraindications for
use of commercially available devices.4-7 Techniques using
snorkels,8 chimneys,9,10 and periscopes,11 which involve the
placement of an aortic graft in parallel with stents or stent
grafts placed into the renal or visceral vessels from alternative
access sites, have been advocated by some clinicians but have
not undergone the rigors of preclinical testing or have been
endorsed by any manufacturers. These techniques remain
unproven clinically and are not sound from an engineering
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emergent setting.12-14 Such techniques remain the only
endovascular means to manage emergency cases of aneu-
rysms involving critical aortic branches given the time delay
required for customization of a fenestrated graft.
Thus, effort has been placed on the creation of off-the-
shelf fenestrated devices. These devices would be required
to accommodate a variety of geometric visceral vessel rela-
tionships in an effort to seal within or above the visceral
aortic segment with a limited amount of stock at hospitals.
This report describes our initial experience with a device
that allows incorporation of the renal arteries and superior
mesenteric artery (SMA) using fenestrations, and the celiac
artery (CA) within a scallop.
METHODS
Patient population. Patients meeting speciﬁc treat-
ment indication and anatomic inclusion criteria (Table I)
were enrolled into a physician-sponsored investigational
device exemption study (National Institutes of Health
Study No. NCT00583050) between August 2011 and
September 2012. All patients signed an informed consent
approved by our Institutional Review Board.
Preoperative assessment. Preoperative high-resolution
computed tomography (CT) scans of the entire chest,
abdomen, and pelvis were obtained to establish the visceral
segment geometry, followed with processing to procedure
a semi-automated centerline of ﬂow reconstruction291
Table I. Instruction for use of Zenith pivotal branched (p-branch) device
1. Adequate femoral/iliac access compatible with the required delivery systems.
2. A nonaneurysmal aortic segment proximal to the aneurysm with:
a. A length of at least 4 mm (ie, at least 4-mm circumferential wall contact around fenestrations and/or limits of scallop).
b. A diameter measured outer wall to outer wall of no greater than 31 mm and no less than 21 mm.
c. An angle <60 relative to the centerline of the aneurysm.
d. An angle <45 relative to the supraceliac aorta.
3. Visceral vessel anatomy compatible with Zenith p-branch, speciﬁcally:
a. Renal vessel origins as measured relative to the SMA compatible with the renal fenestration (ie, both renal vessel origins within
7.5 mm of the corresponding renal fenestrations, as described in the section as followed).
b. Celiac vessel origin as measured relative to the SMA compatible with the celiac scallop, as described in the section as followed.
In relation to visceral vessel issue, there are two device conﬁgurations (option A and option B) to address a range of patient anatomy:
Option A
d Celiac scallop: 20-mm wide, centered at 12:30 o’clock, 11-mm above SMA
d SMA fenestration: 8-mm diameter, located at 12:00 o’clock
d Right pivot (renal) fenestration: 6-mm inner and 15-mm outer diameter, 5-mm deep, oriented at 9:30 o’clock, 12-mm below SMA
(center-to-center)
d Left pivot (renal) fenestration: 6-mm inner and 15-mm outer diameter, 5-mm deep, oriented at 2:30 o’clock, 12-mm below SMA
(center-to-center)
d Nominal graft length: 146 mm (26- to 32-mm diameter grafts), 151 mm (36-mm diameter graft)
Option B
d Celiac scallop: 30-mm wide, centered at 12:30 o’clock, 9 mm above SMA
d SMA fenestration: 8-mm diameter, located at 12:00 o’clock
d Right pivot (renal) fenestration: 6-mm inner and 15-mm outer diameter, 5-mm deep, oriented at 9:30 o’clock, 16 mm below SMA
(center-to-center)
d Left pivot (renal) fenestration: 6-mm inner and 15-mm outer diameter, 5-mm deep, oriented at 2:30 o’clock, 20-mm below SMA
(center-to-center)
d Nominal graft length: 146 mm (26- to 32-mm diameter grafts), 151 mm (36-mm diameter graft)
SMA, Superior mesenteric artery.
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relationship of all the visceral vessels in relation to the SMA
were recorded on a planning grid (Fig 1).
Device design. The Zenith pivot branch (p-branch)
device (Cook, Bloomington, Ind) is a fenestrated graft
(26-36 mm in diameter) designed to work as a single
implant when the distal landing site within a prior aortic
repair is #22 mm or as the proximal component of
a modular bifurcated system that may be combined with
other available Zenith devices. The tubular device is com-
posed of polyethylene terephthalate fabric with a proximal
stainless steel uncovered barbed supraceliac stent, followed
by a series of nitinol z-stents that incorporate a scallop for
the CA, an 8-mm strut-free fenestration for the SMA, and
two renal pivot fenestrations. A circumferential seal is
intended above and below the SMA fenestration, allowing
placement of the device in aneurysms that terminate at least
4 mm below the SMA. Two renal conﬁgurations were
designed, one with renals arising at approximately the same
longitudinal position (67.5 mm), and one with the left
renal artery (LRA) and additional 4 mm caudal (up to 11.5
mm) to the right renal artery (RRA; Fig 2). The renal
fenestrations originate just before a tapered bridging stent
that reduces the device diameter to 24 mm, allowing
mating with any fenestrated distal bifurcated body or
bifurcated iliac branch device.
The pivot fenestration design includes a 15-mmdiameter
fenestration that is ﬂush with the outer wall of the endograft,a funnel shaped section of fabric that is w5 mm long is
directed inward terminating in a 6-mm reinforced fenestra-
tion. This allows for the deployment of the device within
the aorta, providing that the targeted renals reside at least
partially within the outer 15-mm ring. The delivery system
of the Zenith p-branch is 20F (internal diameter). The
implant is secured to the delivery system with proximal and
distal trigger wires and a top cap. A constraining wire is
used such that the graft only partially expands within the
aorta upon sheath withdrawal, allowing the fenestrations
to lie close to the target visceral vessel, while allowing for
movement of the device for optimal positioning. Shaped
catheters are used between the endograft and the target vessel
or within the endograft proper to cannulate the desired
branch. To facilitate cannulation, the pivot fenestrations are
preloaded with a wire over which a sheath can be advanced.
Sizing. The establishment of anatomic acceptability for
use of the p-branch device depends on the location of the
proximal seal, the geometric relationship of the visceral
vessels, and the length of the aorta below the renals. A
seal must be established no less than 4 mm below the
SMA in an aorta that is #32 mm in diameter. The renal
artery locations are viewed relative to their distance from
the SMA. Therefore, the absolute clock positions for any
individual artery are only considered in a manner that is rela-
tive to the other visceral vessels. Thus, signiﬁcant rotation of
the entire visceral segment in a clockwise or counterclock-
wise direction can be accounted for. To determine
Fig 1. Left, The fundamental design of the Zenith pivotal branched (p-branch) standard fenestrated endovascular
graft consists of a tubular graft composed of polyethylene terephthalate fabric with two stainless steel z-stents, including
a bare supraceliac barbed stent, with a scallop for celiac artery (CA) and an 8-mm strut-free fenestration for the superior
mesenteric artery (SMA) (black arrow) and two pivot fenestrations for the right and left renal arteries (red arrows), with
the distal component made of nitinol. Right, The detail of the proximal component system of the Zenith p-branch
shows two options for pivot fenestration locations of the renal arteries with respect to the SMA origin: option A
(upper) and option B (lower). In option A, the pivot fenestrations come off at same longitudinal position of the device
below the SMA. Option B has a staggered longitudinal position of the renal arteries, with the right renal pivot
fenestration being 4 mm higher than the left renal pivot fenestration.
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plotted on a grid. An overlay with acceptable ranges for
each visceral artery (one for each of the two design options)
is set on top of the grid to assess candidacy. If all of the
visceral vessels ﬁt within the overlay targets, then the patient
can be treated with the device. Vessels existing entirely
outside the overlay grid cannot be incorporated into the
device (Fig 2).
Device implantation. Before device implantation, the
3-dimensional CT fusion system is established routinely to
save the intraoperative use of contrast dose during the
procedure.15 After arterial access, anticoagulation, and
placement of a stiff guidewire are achieved, the p-branch
device is advanced such that the SMA fenestration is
aligned with the SMA oriﬁce. The delivery sheath is
withdrawn, and the preloaded renal sheaths are advanced
to the level of the pivot fenestrations. Access into the device
is established from the contralateral femoral artery, the
SMA is cannulated, and a sheath is then placed within
the SMA.
The renals are sequentially cannulated with catheters
and wires through the preloaded sheath. The preloaded
wire is removed, and the renal sheaths are advanced. The
constraining wire is removed, allowing full expansion ofthe graft fabric, and the top cap is deployed by advancing
the central cannula until the reverse taper portion of the
top cap is locked in place. The top cap is then withdrawn
below the renal arteries. A Coda balloon (Cook Medical)
is advanced from the contralateral side and inﬂated at the
level of the pivot fenestrations to “pop” them outward
when anatomically feasible. The mating renal stent grafts
(preferentially, 4- to 9-mm-diameter  28-mm-length
JOMED balloon-expandable covered stent; Abbott
Vascular, Abbott Park, Ill) are then positioned, the renal
sheaths withdrawn, and the stent grafts deployed upon
a balloon sized to the renal artery. The proximal ends of the
renal stent grafts are then ﬂared to 10 mm with a separate
balloon. The SMA stent graft (6-to 12-mm-diameter  28-
mm-length JOMED stent) is then appropriately posi-
tioned, deployed, and ﬂared (Fig 3). The distal portion
of the device is inserted and the contralateral limb or iliac
branch device, or both, is oriented and then deployed.
The later portion of the procedure is performed in a manner
that has previously been described.16
Patient follow-up. CT scans, duplex ultrasound
imaging, physical examinations, and laboratory studies
were obtained within #30 days of the procedure and at
6 and 12 months.
Fig 2. On the sizing sheet of the Zenith pivotal branched (p-branch) device, with a transparent sheet to ﬁt for visceral
vessel anatomy, the blue line is a grid for option A, and the red line is a grid for option B.
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were performed using SAS 9.1 software (SAS Institute,
Cary, NC). Speciﬁc endovascular outcomes, including
technical success, endoleaks, migration, device integrity,
and death were analyzed in accordance with Society for
Vascular Surgery reporting standards.17,18 Data were
stored in an Oracle clinical database (Oracle Corporation,
Redwood Shores, Calif). Technical success was deﬁned as
implant placement at the desired location, stenting of all
fenestrations, the absence of a type I and III endoleak,
and survival through 24 hours.
RESULTS
Preprocedural patient characteristics. This study
included 16 patients (94% men), who were a median age
of 75 years (range, 59-87 years). The median follow-up
was 4.3 months (range, 0.1-12.6 months). Two patients
were treated with a p-branch device for symptomatic
aneurysm, whereas all other patients were considered
elective or semi-urgent with large aneurysms. Additional
demographic data are provided in Table II.
The maximum aneurysm diameter was 61 mm (range,
52-82 mm). The average length of neck below the SMAwas 16.4 mm (range, 5.1-34.4). The median diameter of
the proximal landing zone (above the CA) was 26.2 mm
(range, 21.6-31.0 mm) (Table II). Option A (even renal
arteries) was used in 11 patients and option B in ﬁve
patients (Fig 4). The plots of each visceral vessel (CA,
RRA, and LRA) in relation to the SMA were located at
partially within the overlay grid for option A (Fig 4, a)
and option B (Fig 4, b). One patient, who presented
with a ruptured pararenal aneurysm, was treated off
protocol because the RRA origin was 4 mm inferior to
the acceptable range for the device options (the RRA was
considerably lower than the LRA). Given that the patient
was not an operative candidate, we intended to sacriﬁce
the right kidney using embolization techniques if we could
not incorporate it into the repair. However, we were able
to gain access into all of the visceral vessels in this patient
without an issue.
Procedure data. The technical success rate was 100%.
The median procedure time (from skin incision to skin
closure) was 254 minutes (range, 175-503 minutes) with
a median ﬂuoroscopy time of 62 minutes (range,
38-105 minutes) and contrast volume of 69 mL (range,
31-121 mL). The estimated median blood loss volume
Fig 3. Fluoroscopic image shows full deployment of the Zenith
pivotal branched (p-branch) device with visceral vessel recon-
structions using stent grafts. CA, Celiac artery; LRA, left renal
artery; RRA, right renal artery; SMA, superior mesenteric artery.
Table II. A, Patient demographics and anatomic data
Variables
No. (%) or median (rangea)
(n ¼ 16)
Demographics
Follow-up, months 4.3 (0.1-12.6)
Age, years 75 (59-87)
Male sex 15 (94)
Comorbidities
Hypertension 15 (94)
Hyperlipidemia 12 (75)
Diabetes 4 (25)
Smoking 14 (88)
Coronary artery disease 13 (81)
Myocardial infarction 9 (56)
COPD 6 (38)
Cerebrovascular disease 4 (25)
Chronic kidney diseaseb 1 (6)
Peripheral artery disease 2 (13)
Liver disease 4 (25)
Prior laparotomy 5 (31)
Aneurysm rupture 2 (13)
AAA surgical history 2 (13)
Anatomic data
Maximum aortic diameter, mm 62 (52-82)
Proximal neck length (length of
sealing zone below SMA), mm
16.4 (5.1-34.4)
Proximal neck diameter, mm 26.2 (21.6-31.0)
CA, Celiac artery; COPD, chronic obstructive pulmonary disease; SMA,
superior mesenteric artery.
aRange deﬁned as minimum and maximum measurements in each category.
bDeﬁned as creatinine >1.5 mg/dL.
Table II. B, Visceral vessel clock position and distance
from superior mesenteric artery (SMA)
Artery
Clock positiona Distance from SMAa
Median (range) Median (range), mm
CA 12:30 (12:00-12:45) 16.5 (11-27)
SMA 12:15 (11:30-1:00)
RRA 9:30 (9:00-10:15) 11.0 (4-29)
LRA 2:38 (2:00-3:00) 15.0 (4-30)
CA, Celiac artery; LRA, left renal artery; RRA, right renal artery.
aThe clock position and distance from the SMA of the CA, RRA and LRA
are adjusted as the SMA position is at 12:00 o’clock and 0 mm.
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procedures included an iliac conduit in one patient and the
creation of a left internal-to-external iliac bypass in one
patient (Table III).
Follow-up. No patients have been lost to follow-up,
and all patients completed their predischarge and
1-month CT scan. There were no deaths, ruptures, or
conversions after treatment. One patient underwent
a secondary procedure immediately after implantation of
the p-branch due to observed lower extremity ischemia.
This was resolved with the placement of a nitinol stent
within the nonoccluded ipsilateral iliac device limb. The
only late reintervention was performed at 3 months for
a renal stent occlusion. This renal artery was successfullyrecanalized and treated with ballooning and placement of
a distal nitinol stent.
The median length of stay in the intensive care unit
(ICU) was 2 days (range, 1-3 days). Actually, half of the
patients stayed just 1 day in ICU. The others stayed in
the ICU >2 days, especially high-risk patients or aged
patients with many comorbidities. The overall hospital
stay was 5 days (range 3-8 days; Table III).
Fenestrations and branches. There were no issues
with the patency of visceral vessels other than the aforemen-
tioned renal artery occlusion at 3 months. No physiologi-
cally signiﬁcant renal events (including a drop of estimated
glomerular ﬁltration rate by $30%) occurred during the
follow-up in this study. The single renal occlusion was
Fig 4. The clock position and the distance from the superior mesenteric artery (SMA) of the celiac artery (CA) (red
circles), right renal artery (RRA) (blue circles), and left renal artery (LRA) (yellow circles), as the SMA clock position and
distance position is adjusted to at 12:00 o’clock and 0, respectively, is shown for (a) option A (n ¼ 11) and (b) option B
(n ¼ 5). *Represents a patient with rupture who was treated off protocol.
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ﬁltration rate (39 mL/min preoperatively to 40 mL/min
after renal occlusion). However, the patient washypertensive (195/88 mm Hg), possibly affected by this
RRA occlusion. The etiology of the renal occlusion likely
related to a narrowed visceral segment incorporating the
Table III. Procedural and postoperative outcomes
Variable
No. (%) or median
(range) (n ¼ 16)
Technical success 16 (100)
Procedure time, minutes 254 (175-503)
Fluoroscopy time, minutes 62 (38-105)
Contrast media dose, mL 69 (31-121)
Blood loss, mL 200 (0-1000)
Adjunctive procedure
Iliac conduit 1 (6)
Left EIA-IIA bypass 1 (6)
Mortality 0
Myocardial ischemia 0
Pulmonary failure 0
Renal failure 0
Spinal cord ischemia 0
Late event
Limb ischemia (perioperative) 1 (6)
RRA stent occlusion (3 months later) 1 (6)
Intensive care unit stay, days 2 (1-3)
Hospital stay, days 5 (3-8)
EIA, External iliac artery; IIA, internal iliac artery; RRA, right renal artery.
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celiac and SMA was 30 mm, and the aortic diameter at the
RRA level was 17 mm. A 32-mm device was used, but the
effect of this oversizing of the graft at the level of the RRA
was not appreciated and resulted in the renal stent abutting
the aortic graft, ultimately leading to occlusion. A secondary
procedure was successful at renal recanalization. The
patient’s renal function has remained stable, and his blood
pressure was lower (138/70 mm Hg) for 5 months
thereafter.
DISCUSSION
The last decade has heralded the endovascular manage-
ment of simple as well as complex aortic diseases. In 2006,
the number of AAAs treated with endografts exceeded the
number of open repairs.19 According to the 2005 National
Inpatient Sample data, the overall number of AAA repairs
increased, with the number of ruptured aneurysms signiﬁ-
cantly decreasing.20 The management of more hostile
proximal necks involves the use of snorkels, periscopes, or
chimneys in emergency settings, whereas customized fen-
estrated and branched devices have been electively used
to treat aneurysms involving the visceral segment.21-27
Visceral bypass, followed by endografting,28,29 has been
used, but complication rates remain similar to that of
open repair.30,31 The need for more rapid availability of
endovascular devices capable of addressing aneurysms
involving the visceral aneurysms will allow for the treat-
ment of urgent cases and may also deter off-label device
use where infrarenal devices are used inappropriately,
combined with other adjuncts, to create more proximal
landing zones or are modiﬁed intraoperatively. The estab-
lished use of fenestrated and branched devices has been
previously reported with respect to technical success,32
visceral vessel patency,33 survival,25 and durability.34The two primary criticisms of the technique are the
technically challenging nature of the repair and the need
for customized devices, which often cause considerable
delays in repair timing. To address these issues, an off-
the-shelf fenestrated device was developed and tested
within the context of a physician-sponsored investigational
device exemption trial. This design is intended to treat
patients with juxtarenal and pararenal aneurysms, provided
a healthy neck exists below the SMA. In addition to an
adequate proximal neck for sealing and ﬁxation, the
geometric relationship of the visceral vessels is critical to
the proper selection of patients. The pivot fenestration
design provides a means of accommodating a range of
anatomies using one or two visceral conﬁgurations of vari-
able diameters. Our analysis of 288 juxtarenal AAA patients
treated with custom devices at our institution from 2001 to
2011, where a proximal seal can be established >4 mm
below the SMA, indicates that w72% of patients can be
treated with this p-branch device, 54% with option A and
49% with or option B, with neck applicability of 97% and
visceral vessel applicability of 75% (Fig 5).
However, the RRA in the ﬁrst patient we treated in the
setting of a ruptured aneurysm was considerably lower than
the LRA and did not meet the inclusion criteria for the
device. The patient was treated off protocol with the
understanding that we would potentially sacriﬁce one of
the kidneys. Fortunately, we were able to gain access to
both renals and the SMA without difﬁculty, prompting
us to modify the protocol and providing more liberal inclu-
sion criteria for patients presenting with ruptured aneu-
rysms (by increasing the range by an additional 7.5 mm
cranially and caudally). We did not apply this change to
elective patients, given that testing on potential fatigue,
access challenges, or other issues with speciﬁc anatomies
using such a device conﬁguration has not been completed.
This issue raises a fundamental question of how we, as
clinicians, will balance the use of standard off-the-shelf
devices with anatomy that may be better handled with
speciﬁc, customized designs. If manufactures agree to
supply many conﬁgurations of off-the-shelf visceral vessel
geometries in the requisite diameters, more patients could
be treated with off-the-shelf devices. However, to truly
function as an off-the-shelf device, hospitals would have
to stock the each of the device conﬁgurations in the appro-
priate diameters, the mating components, and other ancil-
lary equipment. If case volume is not particularly high and
the required stock is voluminous, these devices will not be
viewed as off-the-shelf. In contrast, if physicians push the
limits of off-the-shelf devices, forcing speciﬁc conﬁgurations
to treat anatomic situations that are at the fringe or
even outside of their intended designs, we will likely see
higher rates of technical failures in conjunction with late
durability issues. If such devices are used off-label and prob-
lems are created, such as proximal endoleaks or failure to
incorporate renal vessels, the repercussions are potentially
far more dangerous than use of infrarenal devices because
bailout options do not exist and open conversion will
be markedly more complicated. Thus, there must be
Fig 5. The applicability of the Zenith pivotal branched (p-branch) device for 288 patients with juxtarenal abdominal
aortic aneurysm in our institution from 2001 to 2011. Positions are shown for the celiac artery (CA) (red dots), right renal
artery (RRA) (blue dots), and left renal artery (LRA) (yellowdots) (1mmdiameter).Theoverall applicability of p-branchwas
72% (neck applicability; 97%, visceral vessel applicability; 75%), strictly followed by the inclusion criteria of p-branch.
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tested with appropriate in vitro simulations and then care-
fully clinically evaluated to establish appropriate guidelines
for physicians.
Ready device availability of an off-the-shelf device
intended for widespread use and applicable to emergency
situations procedures must also be easy to plan, have
a limited number of components, available mating devices
for the visceral arteries, and the implantation procedure
should be relatively simple. The most critical step for plan-
ning a p-branch procedure is an assessment of the proximal
landing zone immediately below the SMA. Inadequate
sealing and ﬁxation zones should preclude device use.
Next, a plot of the visceral vessel locations relative to the
SMA is produced on a grid that is then ﬁtted with an over-
lay of one of the two designs. This allows for the determi-
nation of visceral vessel acceptability and the choice of the
two device conﬁgurations. Finally, a measurement of the
infrarenal aortic length is required.
Implantation is simpler than with conventional fenes-
trated devices. After alignment of the SMA fenestration
with the ostium (longitudinally and radially), the sheath
can be withdrawn, allowing the graft to partially expand.
The renal fenestrations will automatically be properly
aligned, and access can then be established into all
branches. The preloaded catheters, wires, and sheathseliminate several steps that are required during conven-
tional fenestrated procedures. However, they sometimes
could not work well (eg, tortuous abdominal aorta or small
intravascular diameter at renal levels), which necessitates
a conventional renal access through the contralateral
femoral artery, although this is quite rare.
The incorporation of the SMA with a fenestration
rather than a scallop was intended to allow for a longer
segment of circumferential aortic sealing. In most of our
early cases, the design incorporated the SMA into
a scallop35; however, close analysis showed that many of
the juxtarenal aneurysms and all pararenal aneurysms had
ectasia that extended well above the renal arteries close
to the SMA. This becomes most apparent when CT recon-
structions are viewed from a lateral perspective, appearing
as a posterior bulge. This noncircular aortic geometry
impedes optimal sealing of typical z-stents and is indicative
of disease within the visceral segment that may progress in
a longitudinal manner. Where the disease ends (ie, at the
renals, SMA, or more proximally) is often not apparent
from current imaging techniques. This is now a commonly
observed failure mode of early fenestrated grafts because
the extended follow-up of patients with limited visceral
vessel incorporation includes proximal endoleaks and
migration that are attributed to longitudinal disease
progression. Migration of the aortic component, in the
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mating stents, with the potential for vessel loss and serious
consequences.
One could easily argue that an even higher seal and
ﬁxation would be better. If the CA was also incorporated
and a length above the CA was provided, proximal degen-
eration could be easily treated with a thoracic extension.
However, there is likely additional risk incurred by incorpo-
rating the entire visceral segment. As one marches up the
supravisceral segment, there comes a point when the inci-
dence of spinal cord ischemia markedly rises and affects
the balance of design options. Obviously, as fenestrated
devices faildwhether by inappropriate patient selection,
physician error during implantation, device fatigue, or
disease extensiondendovascular salvage techniques are
limited. Extending the device proximally places the overlap
zone within the segment containing the visceral fenestra-
tions, and if the entire visceral segments have not been
incorporated, the upper visceral arteries must be addressed.
Thus, it becomes paramount for the patient’s imaging to
be scrutinized with respect to the presence of disease within
the visceral segment before placement of any fenestrated or
branched device.
Despite the short follow-up for this patient cohort, the
outcomes were excellent, without any deaths, 100% tech-
nical success, and no acute vessel loss. The renal artery
occlusion that occurred at 3 months is indicative of the
potential problems with this therapy in the setting of
narrow aortic segments. Although the sealing zone in this
patient was appropriately sized, a marked taper resulted
in a very narrowed segment in the region of the renal
branches. The mating component of fenestrated grafts
must extend into the aorta (typically 3 mm) to ensure
a seal, and because the renals often come off at the same
level, the residual space within a narrowed aorta becomes
limited. Markedly oversized grafts also take up space and
further narrow the segment, a problem that is not
amenable to balloon dilation given the potential for aortic
rupture of the visceral segment. We believe that such
patients should be excluded unless no other options exist.
This issue exempliﬁes the morphologic complexity in
such patients, because one cannot limit inclusion criteria
to proximal neck diameter and visceral vessel orientation.
The shape and conﬁguration of the aorta in the region of
any branches must also be carefully considered.
This study is limited with respect to the number of
patients treated and the duration of follow-up. In addition,
there was a selection bias, because only patients who met
the strict anatomic inclusion criteria were enrolled, and
there was no overall screening of all potential patients at
our institution. In fact, during the course of enrollment,
a separate fenestrated study (with a different device) was
undergoing recruitment, and the customized Zenith fenes-
trated device became commercially available. Perhaps this
explains the low number of juxtarenal aneurysms treated
because such pathology was readily addressed by either of
the two aforementioned options.CONCLUSIONS
Overall, the early results with the off-the-shelf Zenith
p-branch device are favorable. The minimal morbidity
and absence of mortality compare well with any surgical
series of similar aneurysms. Patient selection remains
crucial, and the need for a careful assessment of the prox-
imal landing zone and healthy region of the aorta cannot
be overemphasized. Branch problems will arise and must
be limited by choosing appropriate morphologies and
also proper implantation techniques. Further study with
such a device is warranted, and multicenter trial designs
are underway.
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term outcomes. Eur J Vasc Endovasc Surg 2006;32:115-23.Submitted Oct 18, 2012; accepted Dec 27, 2012.INVITED COMMENTARYJan D. Blankensteijn, MD, Amsterdam, The NetherlandsFenestrated and branched endografts are further evolutions of
the concept of endovascular aneurysm repair (EVAR). They are
designed to improve the proximal seal in short infrarenal necks and
to make endovascular repair possible in patients with juxta- and
suprarenal aneurysms. Until now, the complex anatomy of the
suprarenal segment of the abdominal aorta has required patient-
speciﬁc custom endograft manufacturing. In the acute and urgent
setting, the off-the-shelf branched device is the Holy Grail to over-
come the associated waiting time of these custom-made devices.
Dr Kitagawa and colleagues describe their initial experience
with the Zenith p-branch standard fenestrated endovascular graft
for the treatment of juxtarenal abdominal aortic aneurysms in 16
(predominantly elective) patients. They describe a 100% technical
success rate and minimal problems during short-term follow-up.
Although these are promising results, the limitations of the article
are also obvious. The study describes a highly selected group of
patients, treated in a high-volume center of excellence and almost
complete absence of follow-up (0, 1-12 months).It is tempting to extrapolate the encouraging long-term results of
the custom-made Zenith fenestrated device, but it must be realized
that this off-the-shelf version is not just a version of the Food and
DrugAdministration-approved fenestrateddevicewith cleverly chosen
geometry. The pivoting renal fenestration is a new design, which is, at
least in theory, one step away from the concept of self-sealing fenestra-
tions. Although the instructions for use in Table I seem to require
a 4-mm seal around all fenestrations, the authors have used the device
in patients with a 4-mm seal distal to the superiormesenteric artery. As
such, the Zenith p-branch system seems to be suggested for pararenal
aneurysms in which, consequently, the renal stent grafts act as endo-
graft branches. The durability of this pivot-fenestration seal, however,
is completely unproven and questionable at best.
What will be the impact of this off-the-shelf fenestrated
device? Although the authors optimistically seem to suggest that
72% of juxtarenal aneurysms could be treated with the p-branch
device, careful reading indicates that this percentage comes from
a retrospective study of 288 patients treated in the Cleveland
